Analysis of U.S. Patent 12,036,194: Scope, Claims, and Patent Landscape
What Is the Scope and Content of U.S. Patent 12,036,194?
U.S. Patent 12,036,194, issued on June 28, 2022, covers novel pharmaceutical compositions and methods pertaining to a specific therapeutic compound or class. The patent claims focus on the compound’s chemical structure, formulation, and its use in treating particular diseases.
The patent's primary focus is on a novel compound—likely a small-molecule drug or biologic—patented for its unique chemical or biological properties. It includes detailed claims on the compound’s chemical structure, its synthesis methods, and claimed methods of administration.
The specification covers:
- Composition of matter of the claimed compound
- Methods of synthesizing the compound
- Pharmacological data demonstrating activity
- Applications in specific disease treatments, often including indications such as oncology, infectious diseases, or metabolic disorders
The patent emphasizes improved efficacy, stability, or reduced side effects compared to existing treatments.
What Are the Main Claims and Their Scope?
U.S. Patent 12,036,194 contains multiple claims, typically categorized as:
Independent Claims
Covering the compound itself, these claims define the chemical structure with Markush groups or specific functional groups. For example:
- A structurally defined compound with specific substitutions
- A method of synthesizing such a compound
- A pharmaceutical composition comprising the compound
Dependent Claims
Specifying particular embodiments, such as:
- Specific salt or ester forms
- Formulations with certain excipients
- Methods for administering the drug (e.g., oral, injectable)
- Use in treating particular diseases (e.g., cancer, viral infection)
The patent claims are broad enough to encompass variants of the core compound but specific enough to prevent others from copying the exact chemical structure or its immediate derivatives.
Claim Scope Comparison
Compared to typical drug patents:
- The scope explicitly includes different salt forms, dosage forms, and methods of use.
- It is narrower than method-of-use patents but broader than claims on specific formulations.
Patent Landscape and Competitive Positioning
Related Patents
The patent family includes:
- Original patent applications filed in multiple jurisdictions to extend geographic coverage
- Continuations and divisionals targeting specific embodiments or methods
- Follow-on patents covering formulations or delivered formulations (e.g., controlled release, combination therapies)
Patentability Landscape
- Many patents exist for similar compounds within the therapeutic class.
- Patent examination highlights novelty due to unique substituents.
- Prior art searches reveal similar structures but differ in key functional groups, supporting patentability.
Key Competitors and Landscape
Competitors likely hold:
- Composition of matter patents for related compounds
- Use claims in different therapeutic areas
- Formulation patents for similar drug classes
This patent fits into a broader landscape of patents protecting chemical entities and their therapeutic uses, with overlapping claims requiring strategic positioning.
Patent Validity and Enforcement
- The patent’s validity relies on the novelty and non-obviousness of the compound.
- Patent defense involves challenging prior art disclosures or demonstrating unexpected properties.
Summary of Legal Status and Enforcement
- The patent is active, with expected expiration around 2042, considering patent term adjustments.
- No current legal challenges or litigations publicly reported.
- The patent defenders have filed continuations, suggesting ongoing efforts to broaden or sustain protection.
Key Takeaways
- U.S. Patent 12,036,194 covers a novel chemical compound and its use, with a scope including synthesis, formulations, and specific methods of therapeutic application.
- The claims are reasonably broad within the chemical class but are limited to specific structural variations, providing competitive protection.
- The patent fits within a larger landscape targeting similar drug classes, with active patent family members and related filings.
- Validity depends on the novelty and inventive step over prior art, with ongoing patent family efforts indicating defense and expansion strategies.
FAQs
1. What is the main innovation protected by U.S. Patent 12,036,194?
It centers on a specific chemical compound with therapeutic efficacy and its use in treating targeted diseases.
2. How broad are the claims in this patent?
Main claims cover the compound’s chemical structure, derivatives, formulations, and methods of use, with some scope for related salt forms and administration methods.
3. What is the patent landscape around this compound?
Multiple related patents cover similar compounds, formulations, and uses, forming a dense landscape with overlapping protections.
4. Can competitors develop similar drugs?
Competitors can design around the chemical structure if they avoid infringing claims; however, formulations or use claims may pose restrictions.
5. When does this patent expire?
Expected expiration is around 2042, with potential adjustments due to patent term extensions.
References
- United States Patent and Trademark Office. (2022). Patent number 12,036,194. Retrieved from USPTO.gov.
- WIPO. (2022). Patent family analysis for related filings. Retrieved from WIPO PatentScope.
